AJAgnes Jonathan

Agnes Jonathan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Agnes Jonathan has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Implementation of Newborn Screening for Sickle Cell Disease Program in Selected Hospitals in Dar es Salaam, Tanzania

    by Tunganege Matipa, Elia Nyangi, Agnes Jonathan, Mwashungi Ally, Lulu Chirande, Asteria Mpoto, Emmanuel Balandya, Gladys Reuben Mahiti

    Sickle cell disease (SCD) is a major public health concern in Tanzania where approximately 11,000 children are born with the condition annually. Newborn screening (NBS) enables early diagnosis and timely intervention. Despite the proven effectiveness of NBS in reducing early mortality from SCD, implementation in Tanzania remains limited to pilot programs at facilities such as Temeke and Amana Regional Referral Hospitals (RRHs) in the city of Dar-es-salaam. This study evaluated the implementation of NBS for the SCD Program at Temeke and Amana RRHs. An explanatory mixed-methods process evaluation was conducted between January 2022 and December 2024. Quantitative data were extracted from hospital registries and REDCap, while qualitative data were obtained from key informant interviews with 17 healthcare workers. Quantitative data were analyzed using SPSS v29.0, while qualitative transcripts were thematically analyzed using NVivo software version 15 to explore operational factors influencing implementation. A total of 10,711 newborns were screened across the two hospitals. Seventy-four (0.70%) newborns had homozygous SCD (HbS/S), whereas 1325 (12.53%) had sickle cell trait (HbA/S). Enrolment of infants diagnosed with SCD into comprehensive care declined substantially over time, from 65.6% in 2022 to 10.5% in 2024 at Temeke RRH, while Amana RRH recorded no enrolments beyond the first year of implementation. Qualitative findings highlighted facilitators for NBS such as maternal awareness, interdepartmental collaboration, and the availability of trained staff. However, implementation was hindered by inadequate refresher training, delayed staff incentives, supply shortages, and parental hesitancy influenced by cultural beliefs. This evaluation found a substantial decline in enrolment of newborns diagnosed with SCD into comprehensive care, driven by key operational challenges. Although early implementation benefited from trained, committed staff and interdepartmental collaboration, sustainability was limited by inadequate refresher training, delayed incentives, supply shortages, and parental hesitancy. Addressing these gaps through regular capacity building, strengthened supply chains, timely incentives, and culturally sensitive community education is critical to improving enrolment, continuity of care, and informing national scale-up of NBS for SCD in Tanzania.

  • Open Access

    Factors Affecting Pain Control in Patients with Sickle Cell Disease at Mwananyamala and Muhimbili Hospitals in Dar es Salaam, Tanzania

    by Happiness Joseph Igogo, Mbonea Yonazi, Ritah F. Mutagonda, Avelina Mgasa, Mwashungi Ally, Clara Chamba, Ahlam Nasser, William Mawalla, Magdalena A. Lyimo, Benson Kidenya, et al.

    Background/Objective: The most common hemoglobin disorder in the world is SCD. The majority of SCD cases come from Africa, accounting for up to two-thirds of the 300,000 annual births of individuals with SCD worldwide. In Tanzania, 11,000–14,000 babies are born with SCD each year. Despite treatment advancement, pain is still an attributable cause of admissions among patients with SCD. However, data are still lacking regarding the adequacy of pain control in patients with SCD in Tanzania. The aim of this study was to determine factors affecting pain control among patients with SCD presenting with painful events at Mwananyamala Regional Referral Hospital (MRRH) and Muhimbili National Hospital (MNH) in Dar es Salaam, Tanzania. Methods: This was a cross-sectional study conducted at MRRH and MNH, which are tertiary referral hospitals in Dar es Salaam, Tanzania. Patients with SCD aged 8 years and above who presented at the hospitals with painful events (from August 2022 to February 2023) were enrolled in the study. We used a structured questionnaire to collect data on participants’ socio-demographic characteristics and clinical parameters. The adequacy of pain control was assessed using the WHO Pain Management Index. Multivariable binary logistic regression was used to determine factors associated with pain control. Differences were considered statistically significant when the p-value was p = 0.001), presenting to the hospital with moderate pain (aOR = 2.2, 95% CI [1.3–3.8], p = 0.0060), and presenting to the hospital with a fever (aOR = 3.8, 95% CI [1.1–13.9], p = 0.04). Having severe pain and receiving initial treatment at MRRH and MNH seemed to be protective factors (aOR = 0.33, 95% CI [0.11–0.97], p = 0.04, and aOR = 0.29, 95% CI [0.14–0.61], p = 0.001, respectively). Conclusions: A considerable proportion of patients with SCD receive suboptimal pain control. Receiving initial pain management from another healthcare facility, presenting to the hospital with moderate pain, and having a fever were associated with inadequate pain control. Further research is warranted to elucidate ways of optimizing the management of pain in patients with SCD in Tanzania.

  • Open Access

    SickleInAfrica Consortium: A Seven-Country Study Evaluating the Performance of Dried Blood Spot Point-of-Care Testing in Newborn Screening for Sickle Cell Disease

    by Obiageli Eunice Nnodu, Wilson Mupfururirwa, Sarah Kiguli, Lulu Chirande, Boubacar Ali Toure, Fred Stephen Sarfo, Patience Kuona, Aldiouma Guindo, Andrew Louden, Arthemon Nguweneza, et al.

    Sickle cell disease (SCD) is caused by an inherited single-nucleotide substitution in both copies of the β-globin gene [HBB(Glu7Val)]. The sickle-cell mutation results in the production of an abnor...


  • Open Access

    Factors Affecting Pain Control in Patients with Sickle Cell Disease at Mwananyamala and Muhimbili Hospitals in Dar es Salaam, Tanzania

    by Happiness Joseph, Mbonea Yonazi, Ritah Mutagonda, Avelina Mgasa, Mwashungi Ally, Clara Chamba, Ahlam Nasser, William Mawalla, Magdalena Lyimo, Benson R Kidenya, et al.

    Background: Sickle cell disease (SCD) is the most common hemoglobin disorder in the world. Africa has the highest burden of SCD, accounting for up to 75% of the 300,000 annual births of individuals with SCD worldwide. In Tanzania, 11,000 – 14,000 babies are born with SCD each year. Despite treatment advancement, pain is still an attributable cause of admissions among patients with SCD. However, data is still lacking regarding the adequacy of pain control in patients with SCD in Tanzania. Objective: This study aimed to determine factors affecting pain control among patients with SCD presenting with painful events at Mwananyamala Regional Referral Hospital (MRRH) and Muhimbili National Hospital (MNH) in Dar es Salaam, Tanzania. Methodology: This was a cross-sectional study conducted at MRRH and MNH which are tertiary referral hospitals in Dar es Salaam, Tanzania. Patients with SCD aged 8 years and above who presented at the hospitals with painful events (from August 2022 to February 2023) were enrolled into the study. A structured questionnaire was used to collect data on participants' socio-demographic characteristics and clinical parameters. The adequacy of pain control was assessed using the WHO Pain Management Index. Multivariable binary logistic regression was used to determine factors associated with pain control. Differences were considered statistically significant when the p-value was < 0.05. Results: A total of 390 patients with SCD were analysed with mean age (± SD) of 15 (± 6) years. Most patients were recruited from outpatient clinics (88.2%). The male-to-female ratio was 1:1, the majority of patients had less than three pain episodes per year (77.9%), and most patients presented to the hospital with mild pain (64.6%) and were on Hydroxyurea (62.3%). Furthermore, one-third of patients had inadequate pain control. Factors associated with inadequate pain control included receiving initial pain management in other health facilities (adjusted odds ratio [aOR] and 95% confidence interval [CI] = 2.5 (1.5- 4.5), p=0.001), presenting to the hospital with moderate pain (aOR = 2.2, 95% CI [1.3-3.8], p=0.006), and presenting to the hospital with a fever (aOR = 3.8, 95% CI [1.1 – 13.9], p=0.04). Having severe pain and receiving initial treatment at MRRH or MNH seemed to be protective factors (aOR = 0.33, 95% CI [0.11- 0.97], p=0.04, and aOR = 0.29, 95% CI [0.14 -0.61], p=0.001, respectively). Conclusion: A considerable proportion of patients with SCD receive sub-optimal pain control. Receiving initial pain management from other healthcare facilities, presenting to the hospital with moderate pain, and having a fever were associated with inadequate pain control. Further research is warranted to elucidate ways of optimising the management of pain in patients with SCD in Tanzania.

  • Open Access

    Experience in the adoption of Research Electronic Data Capture (REDCap) as a tool for medical research in Tanzania

    by Raphael Zozimus Sangeda, Upendo Masamu, Daniel Kandonga, Fredrick Mbuya, Liberata Mwita, Frank Makundi, Josephine Mgaya, Elisha Osati, Agnes Jonathan, Bruno P. Mmbando, et al.

    Objective To document the deployment and training of Research Electronic Data Capture (REDCap) at Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania and to evaluate user satisfaction and perceived impact on research practices in Tanzania. Materials and Methods Six structured REDCap training workshops were conducted between 2016 and 2022. The post-training evaluation surveys were completed by 110 participants. Descriptive statistics were generated for demographics and cadres, while Likert-scale responses assessed satisfaction and perceived utility. Diverging stacked bar charts were used to visualize attitudes toward adopting REDCap. Results Most trainees were male (62.7%), aged 26–32 years (52.7%), and affiliated with MUHAS (66.4%), with additional representation from Ghana and Nigeria. The participants included academic or research staff (41.8%), postgraduate students (28.2%), undergraduate students (11.8%), and other professionals (18.2%). Post-training evaluations indicated consistently high satisfaction, with mean scores above 4.4 on a 5-point scale. Trainees strongly endorsed REDCap’s ability to enhance research effectiveness (mean 4.53, SD 0.65), increase productivity (mean 4.52, SD 0.69), and improve task completion (mean 4.50, SD 0.68). More than 85% of the respondents agreed or strongly agreed with the positive statements, underscoring the broad acceptance of REDCap as a reliable tool for research data management. Discussion The findings underscore the importance of structured training in mitigating barriers to adoption and enhancing data quality, efficiency, and institutional visibility. Conclusion Structured REDCap training in Tanzania was associated with high user satisfaction and perceived improvements in research productivity and data quality, offering a scalable model for strengthening data management capacity in sub-Saharan Africa.

  • Open Access

    Level of Healthcare Facility and Psychosocial Factors Influence Perceived Self-Efficacy for Appropriate Use of Hydroxyurea: Experience from Caregivers of Children with Sickle Cell Disease in Tanzania

    by Mwashungi Ally, Deodatus Kakoko, Tone Kristin Omsland, Calvin Swai, Emmy Metta, Kåre Moen, Elia John Mmbaga, Melkizedeck Leshabari, Mbonea Yonazi, Agnes Jonathan, et al.

    Background: Sickle cell disease (SCD) is associated with high physical and psychosocial burden among patients and their families. Hydroxyurea (HU) improves health-related quality of life by preventing SCD complications. Despite its availability, HU is underutilised in Tanzania. Perceived self-efficacy for appropriate medication use influences medication usage among individuals with chronic illnesses. We studied factors associated with caregivers’ perceived self-efficacy for appropriate use of HU and its association with HU usage among children with SCD in Dar-es-Salaam. Methods: We conducted a cross-sectional study from May to August 2023. We enrolled 374 caregivers of children with SCD from two regional and two national hospitals. We adapted the self-efficacy for appropriate medication use scale, a multidimensional perceived social support scale, and a patient health questionnaire for assessment of self-efficacy, social support, and depressive symptoms, respectively. Results: Three-quarters of caregivers had high perceived self-efficacy scores for medication use. Attending national hospitals, high social support, and absence of depressive symptoms were positively associated with perceived self-efficacy (adjusted beta coefficient aβ 2.3, 95% CI 0.5–4.2; aβ 9, 95% CI 7.1–10.9; and aβ 5.3, 95% CI 2.8–7.8, respectively). Caregivers with high self-efficacy were 5.3 times more likely to give HU to their children compared with those with low self-efficacy (incidence rate ratio 5.3, 95% CI 3.3–8.3). Conclusions: Hospital levels and psychosocial factors influence caregivers’ perceived self-efficacy for appropriate HU use. We recommend targeted interventions to enhance psychosocial support among caregivers to increase caregivers’ perceived self-efficacy and HU utilization among children with SCD in Tanzania.


  • Open Access

    Assessment of community knowledge on non-communicable diseases to inform the pilot of WHO PEN-Plus initiatives in selected two districts in Tanzania

    by Gibson B. Kagaruki, Peter Mathias Karoli, Willfredius M. Rutahoile, Pilly Chillo, Reuben Mutagaywa, Aidan Banduka, Edna Siima Majaliwa, Renatus Fabiano Nyarubamba, Esther Mtumbuka, Elizabeth Mallya, et al.

    Background: Non-communicable diseases (NCDs) have increased significantly in Tanzania, accounting for 33% of mortality in the country. Having adequate knowledge translated into practice has a significant effect on the health of individuals through adoption of positive behaviours and influencing better health seeking behaviours. For those already affected by NCDs, it promotes secondary and tertiary prevention by helping them effectively cope with the disease. In this study, we aimed to determine the level and determinants of NCDs knowledge in the community to inform the implementation of WHO PEN- Plus initiatives. Methods: This cross-sectional study was conducted from May to June 2023 involving 528 adults aged 25–64 years from two purposely selected districts and 11, 22 and 528 randomly selected wards, villages, and households respectively. Information on socio-economic, demographic, NCDs knowledge were collected from each participant. Chi-square test and Modified Poisson Regression were applied to assess the association and determinants of NCDs knowledge level. Results: The median age of study participants was 40.5 years. Less than half 42.6%(n=225) were aware of the term NCD and less than one third were aware of the NCD conditions such as Type 1 Diabetes Mellitus (T1DM) 15.3%(n=70), Sickle Cell Disease (SCD) 25.2%(n=133), Rheumatic fever 28.6%(n=151) and Heart failure 33.1%(n=175). Good level of awareness was reported on Type 2 Diabetes Mellitus (T2DM) 79.5%(n=364). More than three quarters of the respondents had low knowledge on T1DM (90.3%), SCD (84.1%), Rheumatic fever (81.3%), NCDs (80.5%) and Heart failure (76.1%). Furthermore, more than half (56.4%) of respondents had low knowledge for T2DM. Adjusted analysis indicated that, for all NCDs except SCD, low knowledge was significantly associated with the district of residence (Kondoa). Low knowledge of NCDs, T2DM, and SCD was significantly associated with having no education, or having only primary or secondary education. Individuals from the lowest, second, middle, and fourth socio-economic status families were significantly associated with low knowledge of NCDs, while the lowest and fourth socio-economic status levels were associated with low knowledge of T2DM and SCD. Conclusion: Low knowledge was observed for all NCDs conditions and socio-economic and demographic characteristics were associated with low knowledge. Interventions to increase NCDs knowledge should consider the socio-economic determinants.


  • Open Access

    Sickle Cell Disease in the Islands of Zanzibar: Patients’ Characteristics, Management, and Clinical Outcomes

    by Ahlam Amour, Fadya Hashim, Fat-Hiya Said, Daniel Joshua, Daniel Kandonga, Michael Msangawale, Agnes Jonathan, Benson Kidenya, Paschal Ruggajo, Marijani Msafiri, et al.

    Background: This study aimed to describe Sickle Cell Disease (SCD) phenotypes, sociodemographic characteristics, healthcare, and clinical outcomes of patients with SCD attending Mnazi Mmoja Hospital (MMH) in Zanzibar. Methods: Individuals who visited MMH between September 2021 and December 2022 and were known or suspected to have SCD were enrolled in the clinic. Sociodemographic characteristics and clinical features were documented, and laboratory tests were performed. A two-sample test of proportions was used to ascertain the significance of differences in the distribution of clinical outcomes between the follow-up visits. Results: A total of 724 patients with SCD were enrolled: 367 (50.7%) were male, and 357 (49.3%) were female. Most patients—713 (98.5%) in total—were homozygous (Hb SS), 9 (1.2%) had the Hb SC phenotype, and 2 (0.3%) had HbS β+ thalassemia. The majority of patients were aged 13 years and below—520 (71.8%) in total—and most did not have health insurance—582 (80.4%) in total. While all patients received folic acid, only a quarter received pneumococcal prophylaxis and hydroxyurea. Attendance at the third visit was associated with a reduced frequency of self-reported episodes of pain (24 patients [4.3%] vs. 11 patients [1.9%]). Conclusion: The population of patients with SCD in Zanzibar mostly comprised children who were Hb SS. Basic care services are still suboptimal, although they are associated with better outcomes when present. Thorough evaluation of SCD prevalence in Zanzibar through newborn screening programs is warranted.

  • Open Access

    Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators

    by Hamu J. Mlyuka, Manase Kilonzi, Ritah F. Mutagonda, Lulu Chirande, Wigilya P. Mikomangwa, David T. Myemba, Godfrey Sambayi, Dorkasi L. Mwakawanga, Joyce Ndunguru, Agnes Jonathan, et al.

    Despite three decades of proven safety and effectiveness of hydroxyurea in modifying sickle cell disease (SCD), its accessibility is limited in Sub-Saharan Africa, which shares 75% of the world’s SCD burden. Therefore, it is time to explore the barriers and facilitators for manufacturing and importation of hydroxyurea for SCD in Tanzania. This was qualitative research that employed a case study approach. Purposive sampling followed by an in-depth interview (IDI) using a semi-structured questionnaire aspired by data saturation enabled us to gather data from 10 participants. The study participants were people with more than three years of experience in pharmaceuticals importation, manufacturing, and regulation. The audio-recorded data were verbatim transcribed and analyzed using thematic analysis. Two themes were generated. The first comprised barriers for importation and manufacturing of hydroxyurea with sub-themes such as inadequate awareness of SCD and hydroxyurea, limited market, and investment viability. The second comprised opportunities for importation and manufacturing of hydroxyurea with sub-themes such as awareness of activities performed by medicines regulatory authority and basic knowledge on SCD and hydroxyurea. Inadequate understanding of SCD, hydroxyurea, and orphan drug regulation are major issues that aggravate the concern for limited market and investment viability. Existing opportunities are a starting point towards increasing the availability of hydroxyurea.


  • Open Access

    The Effects of Sickle Cell Disease on the Quality of Life: A Focus on the Untold Experiences of Parents in Tanzania

    by Manase Kilonzi, Dorkasi L. Mwakawanga, Fatuma Felix Felician, Hamu J. Mlyuka, Lulu Chirande, David T. Myemba, Godfrey Sambayi, Ritah F. Mutagonda, Wigilya P. Mikomangwa, Joyce Ndunguru, et al.

    Tanzania is among the top five countries with a high burden of sickle cell disease (SCD) in the world. Even though the effects of SCD on quality of life have been documented in other countries including Nigeria and the United States of America, few are known from Tanzania. Therefore, this study focused on evaluating the effects of SCD on the quality of life among children living with SCD and their parents. The study employed a qualitative approach to interview purposively selected parents of children who have lived with SCD and have used hydroxyurea (HU) for more than 3 years. The in-depth interviews were conducted with 11 parents of children with SCD at the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar-es-salaam, Tanzania. A semi-structured interview guide was used. Interviews were audio-recorded, transcribed, and thematically analyzed. Three themes were generated including psycho-social effects: family conflicts and divorce, limited access to education, stress and fear; financial effects: Employment limitation, reduced efficiency and productivity, loss of job and lack of self-keeping expenses; and physical effects: physical disability and dependence, and burden of the frequent crisis. Children living with SCD and their parents suffer psycho-social, financial, and physical impacts of the disease. Appropriate interventions should be introduced to minimize the observed effects as ways of improving the quality of life of the individuals living with SCD and their caregivers.